AURELIUS Equity Opportunities SE & Co. KGaA
AURELIUS Group acquires cosmetic clinic operator ‘The Hospital Group’
DGAP-News: AURELIUS SE & Co. KGaA / Key word(s): Takeover AURELIUS Group acquires cosmetic clinic operator “The Hospital Group” – Provider of surgical and non-surgical cosmetic procedures – Complex shareholder circumstances present valuable equity acquisition opportunity – Large synergy potential with AURELIUS Group’s established acquisition Transform Munich / London – July 15, 2016 – AURELIUS Group (ISIN DE000A0JK2A8) today announces the acquisition of “The Hospital Group”, a provider of surgical and non-surgical cosmetic procedures based in Birmingham, UK. With approximately 300 employees, The Hospital Group generated revenues of almost EUR 40 million in 2015. The financial terms of the transaction are undisclosed. The Hospital Group is a leading provider of cosmetic procedures in the UK, as well as a market leader in weight loss treatments. The Company operates the largest cosmetic surgery hospital in Europe together with 15 clinics across Great Britain. The Hospital Group boasts high patient satisfaction rates in its four business areas of cosmetic surgery, weight loss, cosmetic dentistry, and non-surgical treatments. There is significant potential for large revenue and cost synergies between The Hospital Group and Transform Group, which was acquired by AURELIUS in July 2015. Transform, which comprises 27 clinics across the UK and two dedicated cosmetic surgery hospitals in Manchester and London, is the domestic market leader in cosmetic surgery. “With the acquisition of The Hospital Group and Transform, we have reached a leading position in the British market for cosmetic surgery and treatment. We see large growth potential in this market for the coming years,” commented Gerhard Engleder, vice president of AURELIUS Group. ABOUT AURELIUS Currently, the AURELIUS Group consists of 25 subsidiaries with locations in Europe, Asia, and the U.S.A. These include numerous traditional consumer brands, services businesses and a number of industrial enterprises. Companies are acquired based on strict investment criteria without focusing on any particular industry. Shares of AURELIUS Equity Opportunities SE & Co. KGaA are listed in the m:access segment of the Munich Stock Exchange and are traded on all German stock markets under ISIN DE000A0JK2A8. CONTACT
2016-07-15 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English | |
Company: | AURELIUS SE & Co. KGaA | |
Ludwig-Ganghofer-Straße 6 | ||
82031 Grünwald | ||
Germany | ||
Phone: | +49 (0)89 544 799-0 | |
Fax: | +49 (0)89 544 799-55 | |
E-mail: | info@aureliusinvest.de | |
Internet: | www.aureliusinvest.de | |
ISIN: | DE000A0JK2A8 | |
WKN: | A0JK2A | |
Listed: | Regulated Unofficial Market in Berlin, Munich, Stuttgart; Open Market in Frankfurt | |
End of News | DGAP News Service |